FindTrial
Sign In

A clinical study on the treatment for invasive skin carcinoma by Mohs surgery

Research in the management of diagnosis and therapy systems about many dermatosis and STD at Jiangsu province and transformation medical

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-ONRC-13003627
Enrollment
Unknown
Registered
2013-08-29
Start date
2013-10-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

invasive skin carcinoma

Interventions

Mohs surgery group:Mohs surgery
classical extensive operation group::classical extensive operation

Sponsors

Institute of Dermatology, Chinese Academy of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1. Diagnosed SCC, BCC, MM by histopathology before operation; 2. From 18 to 90 years old. Sex is not limited; 3. Participants voluntarily signate on the informed consent forms.

Exclusion criteria

Exclusion criteria: 1. Not clearly in histopathological diagnosis; 2. Metastasis found in the far place organ or lymph node; 3. Severely organic diseases, such as heart, liver, kidney, and metabolic disease,and psychiosis; 4. Genetic and acquired haemorrhagic diseases; 5. Systematical use of corticosteroids or immunosuppressant before operation.

Design outcomes

Primary

MeasureTime frame
Judge whether the skin carcinoma have been removed;—

Secondary

MeasureTime frame
Qulity of life and cosmetic effect;—

Countries

China

Contacts

Public ContactWeida Liu

Institute of Dermatology, Chinese Academy of Medical Sciences

liumyco@hotmail.com+86 025-85470580

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026